Experimental radiation treatment targets elusive cancers
NCT ID NCT07434180
Summary
This study tests whether a new targeted radiation therapy called Lu-177 FAP-2286 can help treat Cancer of Unknown Primary (CUP), where doctors can't find where the cancer started. The treatment delivers radiation directly to cancer cells using a special targeting molecule. The trial will enroll 20 patients whose cancer has worsened after standard chemotherapy and who have specific markers on their tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER OF UNKNOWN PRIMARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.